Aims To evaluate changes in dietary intake following liraglutide treatment, compared to dietitian-supported caloric restriction and a weight-neutral control, and to assess dietary intake against nut…
Aims Type 2 diabetes mellitus (T2DM) significantly increases the risk of dementia, including Alzheimer’s disease (AD), vascular dementia (VaD) and mixed dementia. Although sodium-glucose cotransport…
Yale New Haven Hospital’s Bariatric Surgery program offers award-winning medical services for the treatment of obesity.
International Journal of Obesity – Recent research highlights the promising benefits of glucagon-like peptide 1 (GLP-1) analogs, in managing obesity, glycemic control, and reducing the…
Objective Glucagon-like peptide-1 receptor agonists (e.g., semaglutide) potently induce weight loss, thereby reducing obesity-related complications. However, weight regain occurs when treatment is d…
Some experts say oral versions of popular weight-loss drugs such as Wegovy could offer people more flexibility and accessibility. What’s keeping the pills from taking…
Obesity Surgery – Cooking skills seem to influence individuals’ consumption of ultra-processed foods (UPF). However, there are no studies evaluating this relationship in people who…
Aims The American Diabetes Association recently recommended minimizing ultra-processed food consumption in persons with prediabetes or diabetes to reduce the risk of glycemic progression and…
nts who are not eligible for surgery are managed by percutaneous and endoscopic techniques. There is recent data regarding endoscopic ultrasound-guided gallbladder drainage (EUS-GBD) and…
Aims Glucagon-like peptide-1 (GLP-1) receptor agonists, alongside dual receptor agonists targeting glucose-dependent insulinotropic polypeptide (GIP) receptors, represent transformative therapies fo…
One of the largest and most authoritative collections of online journals, books, and research resources, covering life, health, social, and physical sciences.
